BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 23, 2006
View Archived Issues
Triterpenoids/rexinoid protect mice against lung and ER-negative breast cancer
Read More
Update on Exelixis oncology pipeline: Part II
Read More
Antiarthritic efficacy of GlcNBu shown in a rat model of inflammatory arthritis
Read More
Aeterna Zentaris: Q3 update
Read More
20-HETE inhibition has antiproliferative effects on renal cell carcinoma
Read More
Anti-ICOSL mAb shows promising results in experimental autoimmune glomerulonephritis
Read More
Phase I results show tocilizumab well tolerated, active in lupus
Read More
SALT-1 and SALT-2 show efficacy of tolvaptan in hyponatremia
Read More
Effects of MC-1 after CABG independent of aortic clamping time
Read More
Snapshots: New data from clinical studies of drug candidates for renal diseases
Read More
UCB's proposed takeover of Schwarz Pharma makes progress
Read More
Prana raises funds to conduct phase IIa study of PBT-2 in early Alzheimer's
Read More
PARI and Kamada collaborate on development of inhaled alpha-1 antitrypsin
Read More
Clearance for first clinical study of BF-1 for prophylaxis of severe migraine
Read More
Orphan drug designation for RG-1068 for MRI of the pancreas
Read More
Pafuramidine awarded orphan drug designation for PCP
Read More
MultiCell's drug candidate shows potential to treat virally induced cancers
Read More
Green Cross granted Korean license to OP-145 for chronic otitis media
Read More
Roche to discontinue codevelopment of daclizumab for transplant maintenance
Read More
Sosei discontinues development of AD-452 for RA based on phase IIb results
Read More
Vascular targeted phototherapy with Tookad shows promise in prostate cancer
Read More
Snapshots of recent studies of bevacizumab on AMD and related conditions
Read More
orBec NDA accepted for review
Read More
Fast track designation for Bronchitol in cystic fibrosis
Read More
Keppra recommended in E.U. for new epilepsy indication
Read More
Recent Vertex and Pfizer patents report novel analgesic agents
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Recent Pfizer and Roche patents report novel therapeutic agents for HCV infection
Read More
Emerging companies showcased at BIO-Europe 2006: Aegera Therapeutics
Read More